DONOR PERIPHERAL BLOOD STEM CELL TRANSPLANT AND PRETARGETED RADIOIMMUNOTHERAPY IN TREATING PATIENTS WITH HIGH-RISK ADVANCED ACUTE MYELOID LEUKEMIA, ACUTE LYMPHOBLASTIC LEUKEMIA, OR MYELODYSPLASTIC SYNDROME: